You may also like
The Prophylactic Use of Fibrinogen Concentrate in High‐Risk Cardiac Surgery
This randomized, controlled trial demonstrates that point‐of‐care guided and prophylactic treatment with fibrinogen concentrate does not reduce transfusion of blood products in a setting of unexpectedly low transfusion rate as tested in this cohort, but may improve coagulation parameters in the setting of high‐risk cardiac surgery.
1 min read
Augmentation of Thrombin Generation in Neonates Undergoing Cardiopulmonary Bypass
We compared recombinant activated factor VII (rFVIIa) with three-factor prothrombin complex concentrate (3F-PCC) for the ability to augment thrombin generation (TG) in neonatal plasma after cardiopulmonary bypass (CPB).
2 min read
Stockert SIII Heart-Lung Machine
The SIII is designed as a complete modular system and can be configured individually according to your requirements.
1 min read